Articles tagged with "disease-modifying antirheumatic drug"

The OPAL Beyond Study: Tofacitinib Phase 3 Results Positive for Treating PsA

December 20, 2016 • By Michele B. Kaufman, PharmD, BCGP

Rheumatology Drug Updates: Infliximab Biosimilar Cross Reacts to Infliximab Antibodies

August 11, 2016 • By Michele B. Kaufman, PharmD, BCGP

Rheumatology Drug Updates on Brentuximab Vedotin, Tofacitinib Citrate

November 17, 2015 • By Michele B. Kaufman, PharmD, BCGP

Oral & Gut Microbiomes Altered in Rheumatoid Arthritis Patients

August 20, 2015 • By Reuters Staff

Antirheumatic Drugs May Be Linked to Pulmonary Toxicity & More

June 24, 2015 • By Michele B. Kaufman, PharmD, BCGP

Why Do We Wait to Help Patients?

June 13, 2011 • By Heather Haley, MS

Cobra Therapy for Rheumatoid Arthritis

June 1, 2010 • By Lilian H.D. van Tuyl, PhD, and Maarten Boers, MD, PhD

Drug Risk Versus Benefit

April 1, 2009 • By Gretchen Henkel